I completed my PhD at Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, where I studied Biochemistry and Molecular Biology. And I am now an associated researcher at Center for Excellence in Molecular Cell Science, Chinese Academy of Science. I have a special interest in the refractory small cell lung cancer, which highly malignant and prone to metastasis, and aim to understand the how tumor plasticity and microenvironment related factors function during small cell lung cancer malignant progression and metastasis.

Education: MD, PhD, University of Chicago Pritzker School of Medicine

Residencies: University of Chicago Medical Center

Fellowships: University of Chicago Medical Center

Board Certifications: Medical Oncology

Dr. Rudin is a board-certified medical oncologist specializing in the care of patients with lung cancer. In addition to serving as Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, He co-chairs the Eastern Cooperative Oncology Group Thoracic Committee, and is a member of the National Cancer Institute Thoracic Malignancies Steering Committee.

He directs a broad research program of therapeutic research with the ultimate goal of improving the outcome for patients with lung cancer. His research includes laboratory-based investigations to identify and test novel treatment approaches to lung cancer, early-phase clinical trials to bring these ideas to the clinic, and later-phase studies to establish the efficacy of these new approaches. They are interested in small cell and non-small cell lung cancers. Some of the strategies his group has explored both in the laboratory and in the clinic include turning back on genes silenced in cancer, re-activating cancer cell death pathways, and treating lung cancer with a cancer-specific virus.

Dr. Triparna Sen, Ph.D., is an Assistant Attending, the Department of Medicine in Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA. She has a broad background in translational oncology research, with a special interest in thoracic malignancies. Her research aims to understand changes in cancer cells at the molecular level that contribute to their growth, metastasis, and drug resistance. She then uses this knowledge to develop improved therapeutic strategies for clinically relevant molecular subsets of lung cancer.

Dr. Sen has received several awards for her contribution to lung cancer research- including the 40 under 40 in Cancer award, AACR Women in Cancer Research scholar award, and AACR Scholar-in-training award. She is the author of several peer-reviewed scientific manuscripts and has received independent grant funding from the Department of Defense, National Cancer Institute (NCI), Lung Cancer Research Foundation, and The International Association for the Study of Lung Cancer (IASLC).

She is actively involved in outreach activities, mentoring, and a passionate advocate of equal opportunity for women in STEM fields. She has served as the two-time president of the Association for Women in Science Gulf Coast Houston Chapter and currently on the leadership board of 500 Women Scientists NYC pod.